We are live on ! Find out more
PCML

Pavaki Capital Management LLC Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$287M
AUM Growth
+$51.4M
Cap. Flow
+$39.9M
Cap. Flow %
13.9%
Top 10 Hldgs %
50.36%
Holding
177
New
21
Increased
16
Reduced
3
Closed
14

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$13.4M
2
QCOM icon
Qualcomm
QCOM
+$9.16M
3
CVX icon
Chevron
CVX
+$4.19M
4
TXT icon
Textron
TXT
+$3.78M
5
MU icon
Micron Technology
MU
+$3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$9.71M
2
DIS icon
Walt Disney
DIS
+$6.12M
3
OGN icon
Organon & Co
OGN
+$1.97M
4
SPHR icon
Sphere Entertainment
SPHR
+$1.39M
5
ESPR
Esperion Therapeutics
ESPR
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 12.55%
3 Materials 9.73%
4 Energy 9.06%
5 Industrials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
26
Advanced Micro Devices
AMD
$789B
$2.32M 0.81%
4,000
NAMS icon
27
NewAmsterdam Pharma
NAMS
$3.34B
$2.26M 0.79%
66,600
+30,000
+82% +$989K
QQQM icon
28
PUT
Invesco NASDAQ 100 ETF
QQQM
$102B
$2.12M 0.74%
7,000
+4,000
+133% +$1.13M
SSRM icon
29
SSR Mining
SSRM
$6.48B
$2.12M 0.74%
75,000
PSKY
30
Paramount Skydance Corp
PSKY
$10.3B
$2.06M 0.72%
208,863
DOUG icon
31
Douglas Elliman
DOUG
$162M
$1.81M 0.63%
1,022,552
+8,800
+0.9% +$15.8K
EWS icon
32
iShares MSCI Singapore ETF
EWS
$1.08B
$1.78M 0.62%
60,000
ORLY icon
33
CALL
O'Reilly Automotive
ORLY
$76.3B
$1.77M 0.62%
19,200
BIO icon
34
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.76M 0.61%
6,000
FSK icon
35
FS KKR Capital
FSK
$3.44B
$1.68M 0.59%
160,100
+150,100
+1,501% +$1.61M
TOL icon
36
PUT
Toll Brothers
TOL
$14.5B
$1.65M 0.57%
10,000
AZO icon
37
CALL
AutoZone
AZO
$51.1B
$1.6M 0.56%
500
HAL icon
38
Halliburton
HAL
$26.6B
$1.56M 0.54%
46,000
+30,000
+188% +$1.17M
SPY icon
39
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$1.49M 0.52%
2,000
-1,700
-46% -$1.23M
BIDU icon
40
Baidu
BIDU
$37.2B
$1.49M 0.52%
13,000
EPHE icon
41
iShares MSCI Philippines ETF
EPHE
$145M
$1.4M 0.49%
58,000
+10,000
+21% +$248K
SMH icon
42
PUT
VanEck Semiconductor ETF
SMH
$73.2B
$1.31M 0.46%
+2,000
New +$1.09M
SNDX icon
43
Syndax Pharmaceuticals
SNDX
$1.82B
$1.31M 0.46%
60,000
CRM icon
44
CALL
Salesforce
CRM
$158B
$1.25M 0.44%
8,000
YUMC icon
45
Yum China
YUMC
$16.3B
$1.23M 0.43%
30,000
KGC icon
46
Kinross Gold
KGC
$32.8B
$1.17M 0.41%
49,500
ERIC icon
47
Ericsson
ERIC
$33.3B
$1.09M 0.38%
97,500
+52,500
+117% +$633K
GDX icon
48
PUT
VanEck Gold Miners ETF
GDX
$27.4B
$1.06M 0.37%
+14,000
New +$1.24M
PLTR icon
49
PUT
Palantir
PLTR
$413B
$1.05M 0.37%
9,000
OGC
50
OceanaGold Corp
OGC
$6.25B
$1.01M 0.35%
+40,200
New +$1.2M

Similar funds

Pavaki Capital Management LLC's Q2 2026 Portfolio in Review

As of Q2 2026, Pavaki Capital Management LLC held 177 positions worth $287M, up 22% from $235M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management LLC deployed $39.9M of net new capital in Q2 2026, opening 21 new positions and adding to 16 existing holdings. Its largest new stake was Intuit: 38,600 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Intel, an estimated $9.71M trimmed.

  • Pavaki Capital Management LLC's largest Q2 2026 buy was Intuit: 38,600 shares worth $10.1M.
  • Pavaki Capital Management LLC added most to Chevron in Q2 2026, an estimated $4.19M increase.
  • Pavaki Capital Management LLC's biggest Q2 2026 reduction was Intel, cutting an estimated $9.71M.
  • Pavaki Capital Management LLC fully exited Organon & Co in Q2 2026, selling an estimated $1.97M.
  • Pavaki Capital Management LLC's ten largest holdings make up 50% of its $287M portfolio in Q2 2026.
  • Pavaki Capital Management LLC opened 21 new positions and closed 14 in Q2 2026.
  • Pavaki Capital Management LLC's portfolio value rose 22% quarter-over-quarter to $287M.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.